Nineteen cases of the t(1;22)(p13;q13) acute megakaryoblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group TO 
THE EDITOR
Annual incidence of haematologic malignancies in childhood is around 50 cases per 10 6 , 1 of which acute non-lymphocytic leukaemias (ANLL) account for 10%. M7 ANLL occur at any age, in particular in infants/children younger than 2 years and in adults older than 50 years. M7 represents 10% of childhood ANLL and 0.5-1% of adult ANLL. 2, 3 M7 is a heterogenous disease, comprising at least three entities: M7 with t(1;22)(p13;q13), M7 in Down syndrome (DS), both found in infants or young children, and M7 cases without DS and without t(1;22), the latter having a typical ANLL age distribution, increasing with age. 4 So far, 24 cases of t(1;22) have been described (ref in http://www.infobiogen.fr/services/chromcancer/StudyGroup/ t0122.html). We add 15 unpublished cases, details of four cases previously quoted in Ref. 5 and present updated data on published cases. This large sample allowed thorough statistical analyses to be performed; each of the clinical or biological parameters was evaluated, but only a very few parameters are significantly correlated, and it was found that none has a prognostic value.
The 19 reported patients have been discovered on 10 different centres. According to FAB recommendations, diagnosis of AML-M7 was based on the presence of more than 30% of megakaryoblasts in bone marrow. These blasts had an undifferentiated or a more differentiated morphology characterized by condensed chromatin and the presence of cytoplasmic blebs, and they did not express myeloperoxidase. According to GEIL recommendations, 6 the immunophenotypic characterization of megakaryoblasts relied on the negativity of lymphoid antigens together with either the positivity of two megakaryoblastic markers or the expression of one megakaryoblastic marker associated with CD36 positivity. Karyotypes were obtained from bone marrow and/or blood samples (24 h culture, GTG and/or RHG banding). In cases with +21, a constitutional karyotype was requested to assess normality or detect a constitutional chromosome abnormality. Statistical analyses were performed using Fisher's exact test, and for comparisons between survivals, logrank test. Complete and detailed clinical, haematological and cytogenetic data on each of the 39 cases are available at the following URL: http://www.infobiogen.fr/ services/chromcancer/StudyGroup/t0122.html.
Diagnosis
A M7-ANLL was diagnosed in 35 of 39 t(1;22) cases. The four remaining cases are as follows: a case of M6 was reported as such before the M7 subtype had been defined; 7 as already noted, the diagnosis of M7 may be difficult when criteria cannot be reached or when morphology assessment cannot be performed, and this occurred in two of our cases, therefore diagnosed as M0 and M1. One of our cases was diagnosed as hepatoblastoma, despite the fact that all the haematological criteria fit a haematological malignancy. BM smears could not be reviewed. Myelofibrosis and fibrosis of other organs involved in the malignant process, together with the prominent organomegaly, have at times mimicked a solid tumour, inasmuch as CD45 has been found negative 8 and misdiagnoses have been documented; altogether, seven of 39 cases (18%) have had an initial diagnosis of solid tumour: epitheliod haemangioendothelioma, metastatic neuroblastoma, carcinoma, neuroblastoma vs M7, hepatoblastoma, and metastatic undifferentiated sarcoma in two cases before re-biopsy and revised diagnosis of M7 (Refs 8 and 9, and four of our cases, respectively). We assume that translocation t(1;22) is, in fact, restricted to infant/childhood megakaryoblastic leukaemia. 
Frequency
Frequency of t(1;22) leukaemia ranges from 0% to 3% of childhood ANLL; 3, 10 we confirm the rarity of this anomaly as there were only 19 patients discovered in 10 different centres, and many other centres from various countries had no cases at all to include.
Background
Although the risk of M7 is x500 in DS, 11 no case of DS was found with a t(1;22)/M7: these two major childhood M7-ANLLs appear so far to be self-exclusive. There was no preceeding myelodysplasia, and no history of transient leukemoid reaction (a disease of the megakaryocytic lineage), in contrast with cases of M7 in DS. 2, 4, 12 No toxic exposure could be noted in t(1;22) cases, although infant leukaemias have been suspected to have an environmental component; moreover, some leukaemias such as the 11q23 and the t(8;16) leukaemias, known often to be related to genotoxic exposure, are also frequently found in infants.
Age at diagnosis
Infant or congenital leukaemias are defined either by a diagnosis before 1 month, 1 year, or 2 years of life; recent data have given new insights into this debate, showing that two patients aged 5 months and 2 years at diagnosis of leukaemia already had the fusion gene in their neonatal blood spots/Guthrie cards. 13 Median age with the t(1;22) was 4 months and 80% were 1 year old or less at diagnosis (Table 1) . No other leukaemia is found so closely related to infancy. In DS, median age at diagnosis of M7 is around 2 years. 4, 11, 12 A striking finding was that most of the youngest patients had the t(1;22) as the sole anomaly (Table 1) , whereas most of the 'oldest' patients (Ͼ6 months) had a complex karyotype; this difference is highly significant (P = 0.00004). Age at diagnosis, however, is not a prognostic factor.
Sex
Sex ratio was found to be unbalanced (Table 1) , but this was not significant; no difference was found between male and female patients concerning any of the clinical or biological data. In particular, the prognosis was similar in male and in female patients.
Clinical data
Organomegaly is one of the distinctive features of this leukaemia (Table 1) . WBC and platelet counts are higher than in M7 occurring in DS. 4, 12 Thrombocytopenia is a frequent finding in all types of M7, except in the subtype with 3q rearrangements, where thrombocytosis has often been found. 2, 4 Myelofibrosis and fibrosis of other organs are also prominent in this disease (see above).
Karyotype
Twenty-two of 38 cases had the t(1;22) as a single anomaly; as stated above, they were the youngest patients. The remaining cases exhibited complex and hyperploid clones, with a surprisingly highly monomorphic pattern: +der(1)t(1;22), +2, +6, +19, +21 were found in at least 50% of these cases, and other recurring anomalies were: del(1p), +4, +7, +8, +9, +10, +14, +15, +17, +18, +20, add(21p). Survival was equivalent in the two groups. The frequent presence of +der (1) indicates that the crucial event lies on the der(1)t(1;22). One of our cases had a t(1;8;22), which is of interest because this is the first complex t (1;22) . Other recurring anomalies in infant leukaemias are t(5;15)(p15;q11), t(8;16)(p11;p13, 11q23 rearrangements, inv(16) (p13q22), +19, and +21. 
Prognosis
Complete remission (CR) was obtained in only 19 of 36 cases (53%). Median survival was 8 months, with, however, a few long-term survivors that updating allowed us to discover (Figure 1) . In other childhood M7, CR is obtained in 60-80% of cases, 3, 15 and median survival is 5-9 months, 3,4,15 comparable 15 with or worse 3 than in other ANLL subtypes. M7-ANLL has proved to have a better prognosis in DS, with a 4 year event-free survival of 73%. 12 Bone marrow transplantation is indicated in cases with t(1;22), 10 as it also appears to be indicated in other M7-ANLL, 2 except in DS.
12
Genes
The genes involved in this leukaemia are still unknown: this chromosome anomaly is rare, sampling is very poor (BM fibrosis), and a poor outcome most often excludes further studies.
Figure 1
Overall survival in 39 patients with a t(1;22)(p13;q13) M7-ANLL. 1,2 Recent studies of immunoglobulin kappa (IGK) gene rearrangements using Southern blot and PCR strategies have demonstrated that rearrangements of the kappa deleting element (Kde) occur in approximately 50% of Blineage ALL. 3, 4 Almost all IGK gene deletions are mediated via Kde which recombines either to one of the V elements or to the recombination signal sequence in the intron between J5 and C (intron RSS). Kde rearrangements are much more stable during the progression of ALL than other Ig or TCR recombinations and can therefore be regarded as ideal markers for the monitoring of MRD. 4 In B-lineage ALL the VI, VII, and VIII elements are preferentially rearranged to Kde, and RSS-Kde recombinations represent approximately one-third of the Kde rearrangements. 4 We have now established a duplex PCR strategy which allows the rapid identification of the main Kde rearrangements in ALL patients.
We designed two duplex PCRs for the detection of Kde rearrangements which are frequently observed in B-lineage ALL. One duplex PCR (D-PCR 1) amplifies Vl-Kde and RSS-Kde rearrangements, the other (D-PCR 2) detects VII-Kde, VIII-Kde, and VIV-Kde recombinations. 100 ng of genomic DNA were were processed in 70 l of the PCR mixture containing 7 l of 10× buffer, 2.1 l of 50 mM MgCl 2 , 1 U of Taq polymerase (Life Technologies, Karlsruhe, Germany), as well as 200 M dNTP and 30 pmol of each primer. Primers used for D-PCR 1 were VI-5Ј, intron-3Ј as well as Kde-3Ј, and VII-5Ј, VIII-3Ј and Kde-3Ј for D-PCR 2. 5 The mixture was initially heated at 94°C for 4 min and the DNA was amplified using a touch down program whose annealing temperature begins at 66°C and decreases 0.5°C at every cycle on a thermal cycler (Primus96, MWG AG Biotech, Ebersberg, Germany). After the annealing temperature was reached at 52°C in the 28th cycle, 12 additional cycles were performed at 52°C. 10 l of each PCR product was resolved on an agarose gel (FMC, Rockland, ME, USA) containing ethidium bromide. Buffy coat (BC) DNA from healthy volunteers and water were used in every experi-ment as negative controls. Heteroduplex analysis was performed as described. 6 Homoduplex formations of the expected size were considered as indicators of a clonal cell population. 40 l of the PCR products were then electrophoresed on an agarose gel and purified with a QIAEXII Kit (Qiagen, Hilden, Germany). For direct sequencing the appropriate internal primer was used. 5 Sequence analyses were carried out using a Cy5 Thermo Sequenase Dye Termination Kit (Amersham Pharmacia Biotech, Freiburg, Germany) and an autosequencer (ALFexpress II, Amersham Pharmacia Biotech). In cases exhibiting two homoduplex bands in the heteroduplex analysis the PCR product was cloned into a plasmid vector (TOPO TA cloning kit; Invitrogen, Groningen, The Netherlands) prior to sequence analysis. Ten-fold serial dilutions were made of diagnostic DNA into BC DNA. One g of each dilution (from 10 −1 to 10 −6 ), BC DNA as well as H 2 O were amplified with the respective outer primers 5 using the touch down program described above. 5 l of each product was dotted on to a nylon filter. ASO design, end-labelling, and hybridization were carried out as described. 5 Initially we investigated 20 pediatric ALL samples where an IGK rearrangement had been previously detected by Southern blot analysis. 2 By the application of duplex PCR we were able to confirm the results in every patient. Hence, duplex PCR appears to be a reliable strategy for the detection of IGK recombinations. Also DNA samples from healthy volunteers occasionally show amplification products; however, their polyclonal nature can easily be discriminated from the monoclonal pattern of leukemia samples in the consecutive step of heteroduplex analysis. We next characterized IGK gene rearrangements in 34 adult patients with B-lineage ALL enrolled in the multicenter trial GM ALL 05/93. 7 The immunophenotypes comprised four pro-B ALL, 18 common ALL, seven pre-pre-B ALL, three pre-B ALL and two B-ALL. Fourteen patients (41.2%) showed an IGK rearrangement (Table 1 ) and seven patients exhibited two IGK recombinations. Among the 21 rearranged Kde alleles we observed three VI-Kde (14.3%), six VII-Kde (28.6%), five VIII-Kde (23.8%), one VIV-Kde (4.8%), and six RSS-Kde (28.5%) recombinations. We confirm the preferential usage of the A17 element in VII-Kde and of A27 in VIIIKde rearrangements (Table 1) . 4 Recently, Szczepanski et al 8 reported that Kde rearrangements were detected by PCR in eight out of 26 adults (31%) with B-lineage ALL. Since they did not observe RSS-Kde rearrangements in their series of adult ALL patients, they concluded that the absence of RSS-Kde recombinations may reflect one characteristic difference between children and adults with ALL. 8 However,
